Investigation of self-care behaviours in a rat model of acute liver injury induced by paracetamol

Abstract

Aims: Acute liver failure is a clinical condition characterized by sudden onset, high morbidity, and mortality in the absence of any known liver disease. The present study aimed to investigate the status of self-care, anhedonia, and anxiety-like behaviors in a paracetamol-induced acute liver injury (ALI) model. Methods: Twelve adult male Wistar Albino rats were divided into two groups: a control group (n=6) and an acute liver damage group (n=6). The control group received 1 ml/kg physiological saline intraperitoneally (i.p.), while the ALI group received a single dose of 750 mg/kg paracetamol (i.p.). Behavioral tests, including the open field test (OFT), splash test, and sucrose preference test, were performed. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) enzyme levels were measured. Results: AST and ALT levels were higher in the acute liver damage group than in the control group (p<0.05). In the ALI group, the frequency and duration of grooming decreased, and the grooming latency time increased (p<0.001). In the OFT, locomotor activity parameters decreased while anxiety-like behaviors increased (p<0.05). Sucrose solution consumption decreased to below 65% in the ALI group and was significantly reduced compared to the control group (p<0.001). Conclusion: In the ALI model, self-care behavior patterns were negatively affected in duration and frequency. Similarly, locomotor activity and exploratory behavior were decreased, and anxiety-like behaviors increased in the open-field test. Anhedonia was also observed in the sucrose preference test. Further studies on ALI are needed to investigate the negative behavioral changes observed.

Keywords

• Acute live injury
• anhedonia
• anxiety-like behaviors
• self-care behavior
• splash test
• paracetamol

References

1. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet. 2010;376(9736):190-201. doi:10.1016/S0140-6736(10)60274-7
2. Nilsen O, Fisher C, Warrillow S. Update on the management of acute liver failure. Curr Opin Crit Care. 2025;31(2):219-227. doi:10.1097/MCC. 0000000000001253
3. Lemmer P, Sowa JP, Bulut Y, Strnad P, Canbay A. Mechanisms and aetiology-dependent treatment of acute liver failure. Liver Int. 2025; 45(3):e15739. doi:10.1111/liv.15739
4. Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity, and recent pharmacological findings. Inflammopharmacology. 2013;21(3):201-232. doi:10.1007/s10787-013-0172-x
5. Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42(6):1364-1372. doi:10.1002/hep.20948
6. Fontana RJ. Acute liver failure including acetaminophen overdose. Med Clin North Am. 2008;92(4):761-794. doi:10.1016/j.mcna.2008.03.005
7. Huang X, Liu X, Yu Y. Depression and chronic liver diseases: are there shared underlying mechanisms? Front Mol Neurosci. 2017;10:134. doi: 10.3389/fnmol.2017.00134
8. Dogar IA, Siddiqui N, Bajwa A, Bhatti A, Haider N, Hashmi ZY. Relationship between liver diseases and levels of anxiety and depression. J Pak Psychiatr Soc. 2009;6(2):61-64.

9. Abdelghffar EAR, El-Nashar HAS, Fayez S, Obaid WA, Eldahshan OA. Ameliorative effect of oregano (Origanum vulgare) versus silymarin in experimentally induced hepatic encephalopathy. Sci Rep. 2022;12(1): 17854. doi:10.1038/s41598-022-20412-3
10. Kawai H, Ishibashi T, Kudo N, Kawashima Y, Mitsumoto A. Behavioral and biochemical characterization of rats treated chronically with thioacetamide: proposal of an animal model for hepatic encephalopathy associated with cirrhosis. J Toxicol Sci. 2012;37(6):1165-1175. doi:10.2131/jts.37.1165
11. N.R. Council Guide for the care and use of laboratory animals. National Academies Press. 2010.
12. Ishida Y, Kondo T, Ohshima T, Fujiwara H, Iwakura Y, Mukaida N. A pivotal involvement of IFN-'in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J. 2002;16(10):1227-1236. doi:10.1096/fj.02-0046com
13. Mroueh M, Saab Y, Rizkallah R. Hepatoprotective activity of Centaurium erythraea on acetaminophen-induced hepatotoxicity in rats. Phytother Res. 2004;18(5):431-433. doi:10.1002/ptr.1498
14. Çalışkan H, Akat F, Dursun AD, Zaloğlu N. Chronic pregabalin treatment reduced anxiety, and acute pregabalin treatment increased depression-like behaviors in rats. BMC Pharmacol Toxicol. 2024;25(1):72. doi:10.1186/s40360-024-00794-y
15. Çalışkan H, Karakaya D, Koçak S, Ömercioğlu G, Baştuğ M. Effect of high-intensity interval training on self-care and anxiety-like behaviors in naive rats. Exp Brain Res. 2024;242(4):913-920. doi:10.1007/s00221-024-06793-z
16. Verharen JP, de Jong JW, Zhu Y, Lammel S. A computational analysis of mouse behavior in the sucrose preference test. Nat Commun. 2023;14(1): 2419. doi:10.1038/s41467-023-38028-0
17. Burn CC, Peters A, Day MJ, Mason GJ. Long-term effects of cage-cleaning frequency and bedding type on laboratory rat health, welfare, and handleability: a cross-laboratory study. Lab Anim. 2006;40(4):353-370. doi:10.1258/002367706778476460
18. Doğan İ, Doğan N. Estimation of sample size with resource equation method in experimental animal studies. Türkiye Klinikleri J Biostat. 2020;2(2):211-217.
19. Aycan IÖ, Tüfek A, Tokgöz O, et al. Thymoquinone treatment against acetaminophen-induced hepatotoxicity in rats. Int J Surg. 2014;12(3):213-218. doi:10.1016/j.ijsu.2013.12.013
20. Simon P, Dupuis R, Costentin J. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav Brain Res. 1994; 61(1):59-64. doi:10.1016/0166-4328(94)90008-6
21. Yang X, Liu W, Dang P, et al. Decreased brain noradrenaline in minimal hepatic encephalopathy is associated with cognitive impairment in rats. Brain Res. 2022;1793:148041. doi:10.1016/j.brainres.2022.148041
22. Zhou Z, Li K, Guo J, et al. Green tea catechin EGCG ameliorates thioacetamide-induced hepatic encephalopathy in rats via modulation of the microbiota-gut-liver axis. Mol Nutr Food Res. 2023;67(8):e2200821. doi:10.1002/mnfr.202200821
23. Caliskan H, Akat F, Tatar Y, et al. Effects of exercise training on anxiety in diabetic rats. Behav Brain Res. 2019;376:112084. doi:10.1016/j.bbr. 2019.112084
24. Faleiros BE, Miranda AS, Campos AC, et al. Up-regulation of brain cytokines and chemokines mediates neurotoxicity in early acute liver failure by a mechanism independent of microglial activation. Brain Res. 2014;1578:49-59. doi:10.1016/j.brainres.2014.07.001
25. Çalışkan H, Önal D, Nalçacı E. Darbepoetin alpha has an anxiolytic and anti-neuroinflammatory effect in male rats. BMC Immunol. 2024;25(1): 75. doi:10.1186/s12865-024-00665-5
26. Gallego-Durán R, Hadjihambi A, Ampuero J, Rose CF, Jalan R, Romero-Gómez M. Ammonia-induced stress response in liver disease progression and hepatic encephalopathy. Nat Rev Gastroenterol Hepatol. 2024;21(11):774-791. doi:10.1038/s41575-024-00970-9
27. Ott P, Larsen FS. Blood–brain barrier permeability to ammonia in liver failure: a critical reappraisal. Neurochem Int. 2004;44(4):185-198. doi:10. 1016/s0197-0186(03)00153-0
28. Suh JI, Sakong JK, Lee K, et al. Anxiety and depression propensities in patients with acute toxic liver injury. World J Gastroenterol. 2013;19(47): 9069-9076. doi:10.3748/wjg.v19.i47.9069
29. Galland F, Negri E, Da Ré C, et al. Hyperammonemia compromises glutamate metabolism and reduces BDNF in the rat hippocampus. Neurotoxicology. 2017;62:46-55. doi:10.1016/j.neuro.2017.05.006
30. Rama Rao KV, Jayakumar AR, Norenberg MD. Brain edema in acute liver failure: mechanisms and concepts. Metab Brain Dis. 2014;29(4):927-936. doi:10.1007/s11011-014-9502-y